Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 2/20 | 0.58 |
| ▸ | MEN1 | O00255 | 1/20 | 0.58 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.58 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.58 |
| ▸ | MAOB | P27338 | 3/20 | 0.57 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17280821 | 0.98 | MAOB (0.56) | CHRM2MEN1CYP1A2CYP2C19KMT2A | |
| SCHEMBL28375145 | 0.93 | CHRM2 (0.57) | CHRM2MEN1CYP1A2CYP2C19KMT2A | |
| SCHEMBL20472107 | 0.93 | CHRM2 (0.57) | CHRM2MEN1CYP1A2CYP2C19KMT2A | |
| SCHEMBL29740550 | 0.93 | CHRM2 (0.57) | CHRM2MEN1CYP1A2CYP2C19KMT2A | |
| SCHEMBL27203458 | 0.93 | CHRM2 (0.57) | CHRM2MEN1CYP1A2CYP2C19KMT2A | |
| SCHEMBL30242673 | 0.88 | ALDH1A1 (0.59) | CHRM2MEN1CYP1A2CYP2C19KMT2A | |
| SCHEMBL28989527 | 0.88 | ALDH1A1 (0.59) | CHRM2MEN1CYP1A2CYP2C19KMT2A | |
| SCHEMBL14560517 | 0.88 | ALDH1A1 (0.59) | CHRM2MEN1CYP1A2CYP2C19KMT2A | |
| SCHEMBL10215924 | 0.88 | ALDH1A1 (0.59) | CHRM2MEN1CYP1A2CYP2C19KMT2A | |
| SCHEMBL3468557 | 0.87 | MAOB (0.60) | CHRM2MEN1CYP1A2CYP2C19KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6121270-A | N-(EPOXYALKYL)XANTHINE DERIVATIVES WHICH MODULATE CELLULAR RESPONSES TO NOXIOUS, PRO-INFLAMMATORY STIMULI | CELL THERAPEUTICS, INC. (US) | 2000-09-19 | — | — | US | disclosed |
| US-5866576-A | COMPOUNDS THAT ACT AS DRUGS ON THE CELLULAR AND BIOCHEMICAL LEVEL TO MODULATE CELLULAR RESPONSES TO NOXIOUS, PRO-INFLAMMATORY STIMULI. | CELL THERAPEUTICS, INC. (US) | 1999-02-02 | — | — | US | disclosed |
| EP-0662834-A4 | NOVEL EPOXIDE-CONTAINING COMPOUNDS. | CELL THERAPEUTICS INC (US) | 1996-04-17 | — | — | EP | disclosed |
| EP-0662834-A1 | NOVEL EPOXIDE-CONTAINING COMPOUNDS | CELL THERAPEUTICS, INC. (US) | 1995-07-19 | — | — | EP | disclosed |
| WO-1994006431-A1 | NOVEL EPOXIDE-CONTAINING COMPOUNDS | CELL THERAPEUTICS, INC. (US) | 1994-03-31 | — | — | WO | disclosed |